morpholine has been researched along with arecoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Kumar, YC; Malviya, M; Mythri, RB; Rangappa, KS; Subhash, MN; Venkateshappa, C | 1 |
2 other study(ies) available for morpholine and arecoline
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Arecoline; Cerebral Cortex; Dose-Response Relationship, Drug; Humans; Inositol 1,4,5-Trisphosphate; Male; Maze Learning; Memory Disorders; Morpholines; Muscarinic Agonists; Protein Binding; Rats; Rats, Wistar; Receptor, Muscarinic M1; Structure-Activity Relationship | 2009 |